Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist

In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice i...

Full description

Saved in:
Bibliographic Details
Published in:European journal of endocrinology Vol. 169; no. 4; p. R81
Main Author: Shalet, S M
Format: Journal Article
Language:English
Published: England 01.10.2013
Subjects:
Adult
Dwarfism, Pituitary - drug therapy
Dwarfism, Pituitary - economics
Dwarfism, Pituitary - epidemiology
Endocrinology - economics
Human Growth Hormone - therapeutic use
Humans
Hypopituitarism - drug therapy
Hypopituitarism - epidemiology
Models, Econometric
Prevalence
United Kingdom - epidemiology
ISSN:1479-683X, 1479-683X
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients.
AbstractList In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients.In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients.
In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH deficiency (GHD) but withholding it from other patients with even more severe GHD. This approach is counter-intuitive to endocrine practice in treating endocrine deficiency states. For all other endocrine deficiencies, one would opt for treating those with the most severe biochemical evidence of deficiency first. If this endocrine approach was applied to adult GH replacement in an era of rationing, one would start with the GHD patients with a pathologically low IGF1 level. Given that the prevalence of subnormal IGF1 levels in a GHD population is age-dependent, this would result in GH replacement being offered to more young adult onset (AO) GHD and childhood onset GHD adults, and less often to middle-aged and elderly AO GHD adults. This in itself has the added advantage that the skeletal benefits appear more real in the former cohort of patients.
Author Shalet, S M
Author_xml – sequence: 1
  givenname: S M
  surname: Shalet
  fullname: Shalet, S M
  organization: Department of Endocrinology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23904274$$D View this record in MEDLINE/PubMed
BookMark eNpNkM9LwzAcxYNM3A89eZccvVTzTbK0201G3dSBFwfeStp8p5U2qU06tv_ewibs9B6Px4fHG5OBdRYJuQX2AFPBHtPXNAIRMQnJBRmBjGeRSsTn4MwPydj7H8ZAScGuyJCLGZM8liNSp_uA1pc7pLhvsA2lR1paita4oi2tq9zXYU43b9QHbQukzlJtuirQ5Yq22FS6wBptmNPw3SMKZ11d-kB3_hicYfr4mlxudeXx5qQTsnlOPxaraP2-fFk8raMcYiWjbWwEGi6mCjFXElSxTSCfKjCALM-TXImZ1DzRMjEKtGYSwSgDOmYy4Qr5hNwfuU3rfjv0IetHFVhV2qLrfAZSCK6kEtBX707VLq_RZE1b1ro9ZP8X8T_BLGqc
CitedBy_id crossref_primary_10_1016_S0140_6736_16_30053_8
crossref_primary_10_3310_nihropenres_14030_1
crossref_primary_10_1016_j_ghir_2015_03_001
crossref_primary_10_1210_er_2018_00092
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1530/EJE-13-0418
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1479-683X
ExternalDocumentID 23904274
Genre Journal Article
Review
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
5WD
AABZA
AACZT
AAPGJ
AAPXW
AARHZ
AAUAY
AAVAP
AAWDT
ABDFA
ABEJV
ABGNP
ABIME
ABJNI
ABMNT
ABNHQ
ABOCM
ABPIB
ABPQP
ABPTD
ABQNK
ABSQV
ABVGC
ABWST
ABXVV
ABXZS
ACFRR
ACGFO
ACNCT
ACPRK
ACUTJ
ADBBV
ADGKP
ADIPN
ADMTO
ADNBA
ADQBN
ADVEK
ADVOB
AEMQT
AENEX
AFFNX
AFGWE
AFHIN
AFXAL
AFYAG
AGQXC
AGUTN
AHMMS
AI.
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALXQX
ANFBD
APJGH
ATGXG
BAWUL
BCRHZ
BTFSW
C1A
CGR
CS3
CUY
CVF
DU5
E3Z
EBS
ECM
EIF
EJD
EMOBN
F9R
GX1
H13
HZ~
IL9
INIJC
J5H
KOP
KQ8
L7B
NPM
O9-
OAUYM
OBFPC
OBOKY
OCZFY
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
ROX
SJN
TBS
TCN
TEORI
TMA
TR2
VH1
W8F
WOQ
X7M
ZGI
ZXP
7X8
AJBYB
NU-
ID FETCH-LOGICAL-b1764-f7d3ed2356eeb6416cf81b561d1e0bb8b6394a28a48d61aa04e1d6d1a704826e2
IEDL.DBID 7X8
ISSN 1479-683X
IngestDate Thu Oct 02 09:45:14 EDT 2025
Thu Apr 03 06:55:47 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b1764-f7d3ed2356eeb6416cf81b561d1e0bb8b6394a28a48d61aa04e1d6d1a704826e2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://dx.doi.org/10.1530/EJE-13-0418
PMID 23904274
PQID 1433264631
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1433264631
pubmed_primary_23904274
PublicationCentury 2000
PublicationDate 2013-Oct
20131001
PublicationDateYYYYMMDD 2013-10-01
PublicationDate_xml – month: 10
  year: 2013
  text: 2013-Oct
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European journal of endocrinology
PublicationTitleAlternate Eur J Endocrinol
PublicationYear 2013
SSID ssj0016430
Score 2.051078
SecondaryResourceType review_article
Snippet In the UK, through the use of a forced economic model, endocrinologists are in the curious position of offering GH replacement to some patients with severe GH...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage R81
SubjectTerms Adult
Dwarfism, Pituitary - drug therapy
Dwarfism, Pituitary - economics
Dwarfism, Pituitary - epidemiology
Endocrinology - economics
Human Growth Hormone - therapeutic use
Humans
Hypopituitarism - drug therapy
Hypopituitarism - epidemiology
Models, Econometric
Prevalence
United Kingdom - epidemiology
Title Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist
URI https://www.ncbi.nlm.nih.gov/pubmed/23904274
https://www.proquest.com/docview/1433264631
Volume 169
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA7qiHhx3xciiLdgszRJvYjI6OAyeFCY29A0rzCH6YwzKvrvfUkrehEELz0E2oTXl5cvb_sIOfaJ9yXgtaR0XDLlZMIcwgImUwe6SGxhfWQtuTPdru31sofG4TZt0iq_bGI01H5UBB_5KQ-NtrTSkp-Pn1lgjQrR1YZCY5a0JEKZoNWm9x1FwNM2FkQqkzFtZa-pz0tlctq-abPAa6C4_R1bxjPmavm_q1shSw26pBe1OqySGajWyPpFhTfr4Qc9oTHfMzrS18jCfRNWXyfD9nuTyE5jx_9A0EwHFYUKZ54Matf7GX26pQFLFkBHFY2NO-h1h04g5nUFL-MZRThJoa51nr7Qt2k98OMzOLxBnq7aj5cd1vAwMMeNVqw0XoIXMtUATiOCK0oEuwi8PIfEOesQ5ahc2FxZr3meJwq4157nBs2D0CA2yVw1qmCbUDAGdcNJW3qjnNGZEqVIQeZOFT7NxA45-pJvHxcaghd5BaPXaf9bwjtkq_5J_XHdkKMvZBYoQ9TuH97eI4siMFrEfLx90ipxl8MBmS_eULaTw6hA-Ow-3H8CgjXRyA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extensive+expertise+in+endocrinology%3A+UK+stance+on+adult+GH+replacement%3A+the+economist+vs+the+endocrinologist&rft.jtitle=European+journal+of+endocrinology&rft.au=Shalet%2C+S+M&rft.date=2013-10-01&rft.eissn=1479-683X&rft.volume=169&rft.issue=4&rft.spage=R81&rft_id=info:doi/10.1530%2FEJE-13-0418&rft_id=info%3Apmid%2F23904274&rft_id=info%3Apmid%2F23904274&rft.externalDocID=23904274
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-683X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-683X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-683X&client=summon